Three-Dimensional Printing Technology for Medicines

References

1. BoniattiJ. JanuskaiteP. FonsecaL.B. ViçosaA.L. AmendoeiraF.C. TuleuC. BasitA.W. GoyanesA. RéM.I. Direct powder extrusion 3D printing of praziquantel to overcome neglected disease formulation challenges in paediatric populations.Pharmaceutics2021138111410.3390/pharmaceutics1308111434452075
   [Google Scholar]
2. EnglezosK. WangL. TanE.C.K. KangL. 3D printing for personalised medicines: Implications for policy and practice.Int. J. Pharm.202363512278510.1016/j.ijpharm.2023.12278536849040
   [Google Scholar]
3. ParhiR. A review of three-dimensional printing for pharmaceutical applications: Quality control, risk assessment and future perspectives.J. Drug Deliv. Sci. Technol.20216410257110.1016/j.jddst.2021.102571
   [Google Scholar]
4. Pose-BoirazianT. Martínez-CostasJ. EibesG. 3D printing: An emerging technology for biocatalyst immobilization.Macromol. Biosci.2022229220011010.1002/mabi.20220011035579179
   [Google Scholar]
5. CharoenyingT. OpanasopitP. NgawhirunpatT. RojanarataT. AkkaramongkolpornP. PatrojanasophonP. Development of a novel tablet-shaped floating 3D-printed device with adjustable floating time as floating drug delivery systems provided zero-order release kinetics.J. Drug Deliv. Sci. Technol.20238410450610.1016/j.jddst.2023.104506
   [Google Scholar]
6. ShiK. SalvageJ.P. ManiruzzamanM. NokhodchiA. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.Int. J. Pharm.202159712031510.1016/j.ijpharm.2021.12031533540000
   [Google Scholar]
7. KocabasL.I. AyyoubiS. TajqurishiM. QuodbachJ. VermondenT. KokR.J. 3D-printed prednisolone phosphate suppositories with tunable dose and rapid release for the treatment of inflammatory bowel disease.Int. J. Pharm.202464912363910.1016/j.ijpharm.2023.12363938042381
   [Google Scholar]
8. TracyT. WuL. LiuX. ChengS. LiX. 3D printing: Innovative solutions for patients and pharmaceutical industry.Int. J. Pharm.202363112248010.1016/j.ijpharm.2022.12248036509225
   [Google Scholar]
9. Biomedical 3D Printing. Oxford Performance Materials, Inc. Available from: https://www.oxfordpm.com/biomedical-3dp (Accessed April 4, 2024).
10. Triastek | Business Wire.Available from: https://via.ritzau.dk/pressemeddelelse/13611677/triastek?publisherId=90456 (Accessed April 4, 2024).
11. Triastek ReceivesF.D.A. Triastek Receives FDA IND. Clearance for 3D printed product of blockbuster molecule.Available from: https://www.prnewswire.com/news-releases/triastek-receives-fda-ind-clearance-for-3d-printed-product-of-blockbuster-molecule-301519962.html (Accessed April 4, 2024).
12. Triastek’s 3D printed drug T21 shows promise in treating ulcerative colitis - 3D Printing Industry.Available from: https://3dprintingindustry.com/news/triasteks-3d-printed-drug-t21-shows-promise-in-treating-ulcerative-colitis-223735/ (Accessed April 4, 2024).
13. GoyanesA. MadlaC.M. UmerjiA. Duran PiñeiroG. Giraldez MonteroJ.M. Lamas DiazM.J. Gonzalez BarciaM. TaheraliF. Sánchez-PintosP. CouceM.L. GaisfordS. BasitA.W. Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients.Int. J. Pharm.201956711849710.1016/j.ijpharm.2019.11849731279771
    [Google Scholar]
14. Rodríguez-PomboL. de Castro-LópezM.J. Sánchez-PintosP. Giraldez-MonteroJ.M. JanuskaiteP. Duran-PiñeiroG. Dolores BóvedaM. Alvarez-LorenzoC. BasitA.W. GoyanesA. CouceM.L. Paediatric clinical study of 3D printed personalised medicines for rare metabolic disorders.Int. J. Pharm.202465712414010.1016/j.ijpharm.2024.12414038643809
    [Google Scholar]
15. FABRX.Available from: https://www.fabrx.co.uk/home (Accessed April 4, 2024).
16. DiHeSys. FLEXDOSE®. Available from: https://www.digital-health-systems.com/en/wir-bieten (Accessed April 4, 2024).
17. Doser.Available from: https://dosermedical.com/technology/ (Accessed April 4, 2024).